FDA Approves New Treatment for Ovarian Cancer
The U.S. Food and Drug Administration (FDA) has approved a new drug to treat certain types of ovarian cancer in patients who don’t get optimal outcomes from other medicines.The new drug, mirvetuximabAD
AD
Only 1 in 10 Treatments Bring Relief for Acute Low Back Pain, Researchers Learn
Do you experience lower back pain, as so many people do? You’ve probably turned to at least one of many nonsurgical and noninvasive options — and possibly not found relief.Now, a new review of 301 bacEstrogen Patches Are in Short Supply — Is There a Workaround?
If you’re having trouble getting your estrogen patch prescription filled, you’re part of a national trend. Pharmacies around the country are reporting shortages for this form of hormone therapy prescrIs ‘Cold Drink Heart’ a Real Issue for People With Afib?
People with atrial fibrillation (afib) have long reported that consuming cold foods and drinks can trigger episodes of irregular or rapid heart rhythms, only to be brushed off by their doctors. A newAD
Mounjaro Shows Potential as Next Blockbuster Obesity Drug in Late-Stage Trial
The U.S. Food and Drug Administration (FDA)–approved diabetes medication Mounjaro (tirzepatide) is one step closer to approval as a treatment for adults with overweight or obesity.In SURMOUNT-2, a secCommon Medications Could Disrupt Gut Health for Years
Antibiotics are widely known to disrupt gut health by killing “good” as well as “bad” bacteria in the digestive tract.Now scientists are also exploring if other common drugs can interfere with the triAD
AD
